Newman Mary

SVP, Regulatory Affairs at Audentes Therapeutics, Inc.

Sold, on record
$1.1M
Dollars the filings state
Form 4 sales
4
Latest Jun 25, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Audentes Therapeutics, Inc.Unusual
    Aug 24, 2017 2017

    Sold 10,000 shares at $20.00 ($200k)

    Newman Mary, SVP, Regulatory Affairs

    Sold 100% of holdings ($200k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Audentes Therapeutics, Inc.Unusual
    Nov 16, 2017 +84 days

    Sold 10,000 shares at $26.84 ($268k)

    Newman Mary, SVP, Regulatory Affairs

    Sold 100% of holdings ($268k position)0 shares leftFiling

  3. 3 Form 4 sale Audentes Therapeutics, Inc.Unusual
    Mar 15, 2018 +119 days

    Sold 10,000 shares at $30.36 ($304k)

    Newman Mary, SVP, Regulatory Affairs

    Sold 100% of holdings ($304k position)0 shares leftFiling

  4. 4 Form 4 sale Audentes Therapeutics, Inc.Unusual
    Jun 25, 2018 +102 days

    Sold 8,545 shares at $40.79 ($349k)

    Newman Mary, SVP, Regulatory Affairs

    Sold 100% of holdings ($349k position)0 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Newman Mary
Source
Jun 25, 2018Jun 27, 2018Audentes Therapeutics, Inc.SVP, Regulatory AffairsForm 4 sale8,545$349k100.0%UnusualSEC
Mar 15, 2018Apr 2, 2018Audentes Therapeutics, Inc.SVP, Regulatory AffairsForm 4 sale10,000$304k100.0%UnusualSEC
Nov 16, 2017Nov 17, 2017Audentes Therapeutics, Inc.SVP, Regulatory AffairsForm 4 sale10,000$268k100.0%UnusualSEC
Aug 24, 2017Aug 25, 2017Audentes Therapeutics, Inc.SVP, Regulatory AffairsForm 4 sale10,000$200k100.0%UnusualSEC